It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

被引：6
作者：
Oberle, Megan M. [1 ,2 ]
Kelly, Aaron S. [1 ,2 ]
机构：
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Ctr Pediat Obes Med, Minneapolis, MN 55455 USA
来源：
FRONTIERS IN ENDOCRINOLOGY | 2019年 / 10卷
关键词：
GLP-1 receptor agonists; pedatrics; type; 2; diabetes; obesity; weight management; adolescents; DOUBLE-BLIND; WEIGHT-LOSS; LIRAGLUTIDE; PLACEBO; SAFETY; PHARMACOKINETICS; MANAGEMENT; MELLITUS; THERAPY; OBESITY;
D O I：
10.3389/fendo.2019.00738
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 33 条
  • [1] A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients
    Abd El Aziz, Mirna S.
    Kahle, Melanie
    Meier, Juris J.
    Nauck, Michael A.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (02) : 216 - 227
  • [2] Administration UDOFaD, 2018, FDA APPR NEW TREAT P
  • [3] Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis
    Amori, Renee E.
    Lau, Joseph
    Pittas, Anastassios G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02): : 194 - 206
  • [4] Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association
    Arslanian, Silva
    Bacha, Fida
    Grey, Margaret
    Marcus, Marsha D.
    White, Neil H.
    Zeitler, Philip
    [J]. DIABETES CARE, 2018, 41 (12) : 2648 - 2668
  • [5] Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
    Bethel, M. Angelyn
    Patel, Rishi A.
    Merrill, Peter
    Lokhnygina, Yuliya
    Buse, John B.
    Mentz, Robert J.
    Pagidipati, Neha J.
    Chan, Juliana C.
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Ohman, Peter
    Poulter, Neil R.
    Ramachandran, Ambady
    Zinman, Bernard
    Hernandez, Adrian F.
    Holman, Rury R.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (02) : 105 - 113
  • [6] Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents
    Copeland, Kenneth C.
    Silverstein, Janet
    Moore, Kelly R.
    Prazar, Greg E.
    Raymer, Terry
    Shiffman, Richard N.
    Springer, Shelley C.
    Thaker, Vidhu V.
    Anderson, Meaghan
    Spann, Stephen J.
    Flinn, Susan K.
    [J]. PEDIATRICS, 2013, 131 (02) : 364 - 382
  • [7] Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years
    Danne, Thomas
    Biester, Torben
    Kapitzke, Kerstin
    Jacobsen, Sanja H.
    Jacobsen, Lisbeth V.
    Petri, Kristin C. Carlsson
    Hale, Paula M.
    Kordonouri, Olga
    [J]. JOURNAL OF PEDIATRICS, 2017, 181 : 146 - +
  • [8] Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI [10.2337/dci18-0033, 10.1007/s00125-018-4729-5]
  • [9] Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
    Dicembrini, Ilaria
    Nreu, Besmir
    Scatena, Alessia
    Andreozzi, Francesco
    Sesti, Giorgio
    Mannucci, Edoardo
    Monami, Matteo
    [J]. ACTA DIABETOLOGICA, 2017, 54 (10) : 933 - 941
  • [10] Filippatos Theodosios D, 2014, Rev Diabet Stud, V11, P202, DOI 10.1900/RDS.2014.11.202
1234